Medicamentos peligrosos

Autores/as

  • Pedro García Salom Hospital General Universitario, Servicio de Farmacia, Alicante

DOI:

https://doi.org/10.4321/s0465-546x2021000100001

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A, McLennan MT. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J Am Med Assoc. 1946;132(3):126-32. doi:10.1001/jama.1946.02870380008004

Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards. Hosp Pharm. 1981;16(1):17-20.

American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic drugs in hospitals. Am J Hosp Pharm. 1985;42(1):131–7.

American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990;47(5):1033-49.

Burroughs GE, Connor TH, McDiarmid MA, Mead KR, Power LA, Reed LD. NIOSH Alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Atlanta, USA: National Institute of Occupational Safety and Health (NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention; 2004. Report No.: 2004-165.

Connor TH, MacKenzie BA, DeBord DG, Trout DB, O’Callaghan JP. NIOSH List of antineoplastic and other hazardous drugs in healthcare settings, 2014. Atlanta, USA: National Institute of Occupational Safety and Health (NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention; 2014. Report No.: 2014-138.

Erce A, editor. Preventing occupational exposure to cytotoxic and other hazardous drugs: European Policy Recommendations. Brussels, Belgium: Rodhe Public Policy; 2016.

Braun B, Riehle A, Donofrio K, Hazif H, Loeb JM. Improving patient and worker safety: Opportunities for synergy, collaboration and innovation. Oakbrook Terrace, Illinois USA: The Joint Commission; 2012.

Occupational and Safety and Health Administration (OSHA). Controlling Occupational Exposure to Hazardous Drugs [Internet]. Washington DC, USA: OSHA, Department of Labor; 2016 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/39PeWNd

Pan American Health Organization - World Health Organization (PAHO/WHO). Safe handling of hazardous chemotherapy drugs in limited-resource settings [Internet]. Washington DC, USA: PAHO/WHO; 2013 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/2VvLQKe

Instituto Nacional de Seguridad y Salud en el Trabajo (INSST). INFOMED -Información para trabajadores sanitarios sobre medicamentos peligrosos (Internet). Madrid, España: INSST [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3Dcln99

de Jong T, Pawlowska-Cyprysiak K, Hildt-Ciupińska K, Bos E, Nicolescu G, Trifu A, et al. Current and emerging occupational safety and health (OSH) issues in the healthcare sector, including home and community care: European Risk Observatory Report. Luxembourg: European Union Publications Office; 2015.

Prevention of Hazardous Drug Vapor Release by the Tevadaptor® Vial Adaptor (Internet). Bethlehem, USA: B Braun Medical Inc; 2014 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/38b4kpA

MAUDE - Manufacturer and User Facility Device Experience (Internet). Silver Spring, USA: U.S. Food and Drug Administration; 2021 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3gsOJ9x

Zhao C, Radwick A. 5 Challenges of Closed System Transfer Devices (Internet). Bethesda, USA: Parenteral Drug Association; 2020 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/38bcSNb

Casaus Lara ME, coordinadora. Guía de buenas prácticas de preparación de medicamentos en servicios de farmacia hospitalaria (Internet). Madrid, España: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3moQh8l

García Salom P, López Briz E, Moya Gil A, Ferriols Lisart F, Marco Garbayo JL, Vila Clérigues N, et al. Guía para la adaptación de las buenas prácticas en la preparación y manipulación de medicamentos en la Comunidad Valenciana – Instalaciones (Internet). Valencia, España: Generalitat Valenciana; [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3kiOYVF

García Salom P, López Briz E, Moya Gil A, Ferriols Lisart F, Marco Garbayo JL, Vila Clérigues N, et al. Guía para la adaptación de las Buenas Practicas en la Preparación y manipulación de Medicamentos en la Comunidad Valenciana – Equipamiento (Internet). Valencia, España: Generalitat Valenciana; [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3mHdO4H

García Salom P, López Briz E, Moya Gil A, Ferriols Lisart F, Marco Garbayo JL, Gaspar Carreño M, et al. Guía para la adaptación de las buenas prácticas en la preparación y manipulación de medicamentos en los servicios de farmacia en la Comunidad Valenciana – Procedimientos (Internet). Valencia, España: Generalitat Valenciana; [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/3DdRy87

USP <800> Hazardous Drugs - Handling in Healthcare Settings Gap Analysis Survey (Internet). [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/2WbXgH7

Hazardous Drug Consensus Group (HDGC). Consensus Statement on the Handling of Hazardous Drugs Per USP Chapter <800> [Internet]. Cary (NC), USA: Accreditation Commission for Health Care; 2017 [citado 24 de agosto de 2021]. Disponible en: https://bit.ly/37pzVTO

Descargas

Publicado

31-03-2021

Cómo citar

1.
García Salom P. Medicamentos peligrosos. Med Segur Trab [Internet]. 31 de marzo de 2021 [citado 20 de mayo de 2024];67(262):6-10. Disponible en: //revista.isciii.es/index.php/MST/article/view/1136

Número

Sección

Editorial